Laboratory Evaluation of Coagulation and Fibrinolysis Flashcards

1
Q

Things to consider:

A
  1. Tissue thromboplastin contamination
  2. Inappropriate container
  3. Improper temperature: labile factors
  4. Hemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inappropriate container

A

a) Glass surface
b) Polystyrene tubes/ glass tube with silicone- preferred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • preferred
A

Polystyrene tubes/ glass tube with silicone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

@room temp: _______

A

V & VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

@ref temp: _________

A

VII & XI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PT plasma capped stability for 24 hours @: _____

A

RT (18-24oC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

APTT samples stable for 4 hours @: ___________

A

RT (18-24oC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factor assays stable for 4 hours @: ___________

A

RT (18-24oC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hemolysis

A

-prolonged tourniquet application
-moisture/contamination
-inappropriate needle bore
-Frothing of sample
-improper transfer from barrel to tube
-excessive mixing mixing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

▪ Adult (≤25 mL):

A

G20 -21; 1 - 1.25 in.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

▪ Adult (≥25 mL):

A

G19; 1 or 1.25 in.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

▪ Child or adult with small, friable, or hardened veins:

A

G23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

▪ Syringe w/ winged-needle set:

A

G20, 21, or 23 (mostly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

: used in blood donations

A

▪ G16-18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Type of Syringe:

A

Plastic/Silicone coated- single draw
2-way needle and holder-multiple draw
Winged-needle sets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anticoagulants:

A

A) Sodium oxalate
B) Trisodium citrate
4) Heparin
3) EDTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

: Interfere with Spectrophotometric reading (OD)

A

A) Sodium oxalate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

: -Preserves FV and FVIII

A

B) Trisodium citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  • Ratio of 9:1 (blood: anticoagulant)
A

B) Trisodium citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

B) Trisodium citrate Prolonged

A
  • Incomplete filling/high hematocrit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

B) Trisodium citrate
- Two concentrations:

A

3.2% and 3.8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

-acts with antithrombin III to inhibit all stages of coagulation

A

4) Heparin:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

-used for plt retention test

A

4) Heparin:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

-unsuitable for coagulation

A

3) EDTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

-inhibits thrombin-fibrinogen reaction

A

3) EDTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

-Factor V is unstable in its presence

A

3) EDTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Evacuated tube arrangement: 2-way needle collection

A

a. Red stopper
b. Blue stopper (3.2%)
c. Lavander stopper
d. plastic syringe (for additional tests)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

1) Effects of pH: _______

A

PROLONG THE CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

2) Temperature: (as mentioned during the first slide)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

PPP preparation: __________ for _________

A

2000 x g for 10 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Storage: 4 deg within 2 hours/ rapid freezing @:_______________

A

-20oC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PRP preparation: __________ for________@___

A

60-100 x g for 10 mins @ RT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Principle: when venous blood is put into a glass tube, it will form a solid clot.

A

Lee and White Method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

-the time response is a measure of overall intrinsic and common pathway

A

Lee and White Method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

-Insensitive to factor deficiencies.

A

Lee and White Method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Lee and White Method NV:

A

7-15 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Principle: Presence of an activator (DIATOME) and by keeping the blood constant at 37 deg celsius, the test is more reliable and rapid.

A

Activated Clotting Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Activated Clotting Time NV:

A

75-120 sec.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Principle: Time required for blood to clot after the addition of calcium

A

Plasma Recalcification Time (PRT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

-Modified Lee and White

A

Plasma Recalcification Time (PRT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Plasma Recalcification Time (PRT) NV:

A

PRP: 100-150 sec
PPP: 130-240 sec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Routine screening of coagulation disorders in intrinsic system and common pathway

A

Activated partial thromboplastic time (APTT/PTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q
  • Detects the presence of circulating anti-coagulant
A

Activated partial thromboplastic time (APTT/PTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q
  • Monitors heparin therapy
A

Activated partial thromboplastic time (APTT/PTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Principle: Measures all coagulation factors needed for the generation of Intrinsic prothrombinase except for Calcium and PPL

A

Activated partial thromboplastic time (APTT/PTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

When Calcium is added with incomplete thromboplastin (plt substitute- CEPHALIN), intrinsic prothrombinase is generated.

A

Activated partial thromboplastic time (APTT/PTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Activated partial thromboplastic time (APTT/PTT) Specimen:

A

Citrated PPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Activated partial thromboplastic time (APTT/PTT) Reagent:

A

0.025M CaCL2
Phospholipid (plt sub)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Activated partial thromboplastic time (APTT/PTT) Activators:

A

kaolin, celite or ellagic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Activated partial thromboplastic time (APTT/PTT) NV:

A

25-35 seconds/ 22-34 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Prolonged PTT:

A
  1. Deficiency in intrinsic/common pathway factors
  2. Presence of inhibitor
  3. <60 mg/dL fibrinogen
  4. Increased FSP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

-screening for the extrinsic and common pathway coagulation.

A

PROTHROMBIN TIME (Quick’s Test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

-monitors oral anticoagulant with COUMADIN

A

PROTHROMBIN TIME (Quick’s Test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

PROTHROMBIN TIME (Quick’s Test)

Principle: When tissue extract of (?) is added to (?), along with (?), it reacts with (?) to activate (?).

A

thromboplastin (complete)

PPP

Calcium

FVII

FX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

PROTHROMBIN TIME (Quick’s Test) Sample:

A

Citrated PPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

PROTHROMBIN TIME (Quick’s Test) Reagents:

A

Thromboplastin 0.025M CaCL2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

INR=

A

International Normalized Ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

-standardized way of reporting PT in monitoring anticoagulant therapy

A

International Normalized Ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

-calculated as a ratio of the px PT to a control PT (standardized for the potency of the thromboplastin rgt)

A

International Normalized Ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

ISI=

A

International Sensitivity Index (calibration index)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Reference Values for INR

A

2.0-3.0

2.5-3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

2.0-3.0

A

▪ in prevention and treatment of viscous thrombosis
▪ treatment of pulmonary embolism
▪ prevention of stroke in myocardial infarction
▪ peripheral arterial disease
▪ prevention of systemic embolism in atrial fibrillation
▪ cardia valve replacement (tissue valves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

2.5-3.5

A

▪ in prevention of recurrent MI
▪ reduction of mortality in MI
▪ mechanical prosthetic heart valve (high risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

PROTHROMBIN TIME (Quick’s Test)
NV:

A

10-12 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

PROTHROMBIN TIME (Quick’s Test) Prolonged in:

A

-extrinsic and common pathway factor deficiencies
- Fibrinogen of <100 mg/dL
- Dysfibrinogenemia
- Vit K deficiency and certain liver disease
- Increased FDP’s
- False prolongation: heparin contamination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

PROTHROMBIN TIME (Quick’s Test) Shortened in:

A

-Traumatic venipuncture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

is a thromboplastin-like substance

A

Venom “Vipera ruselli”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

STYPVEN/RUSELL’s VIPER VENOM

Principle: Addition of the (?) bypasses the activation of(?) and directly activates (?).

A

venom

VII

FX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

STYPVEN/RUSELL’s VIPER VENOM NV:

A

6-10 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What is the function of Dilute Russel Viper Venome time (dRVVT)?

A

Detects the presence of lupus anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

INDIRECT TESTS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Otherwise known as “Fibrinogen Deficiency Test”

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

THROMBIN TIME

Principle: Addition of thrombin bypasses all coagulation pathways except:

A

polymerization of Fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

.-measures the availability of functional fibrinogen

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

-measures the conversion of fibrinogen to fibrin

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

THROMBIN TIME NV:

A

17-25 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Prolonged TT:

A

Fibrinogen level: 75-100 mg/dL
Impairment of fibrinogen
Presence of Heparin and FDP
Normally prolonged in newborn and multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

REPTILASE TIME NV:

A

18-20 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

REPTILASE TIME Prolonged in:

A

Fibrinogen deficiency
Presence of FSP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Heparin Therapy; NF1 Prolonged

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Heparin Therapy; NF1 Normal

A

REPTILASE TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

FSP: NF1 Prolonged

A

THROMBIN TIME
REPTILASE TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Hypofibrinogenemia Greatly prolonged

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Hypofibrinogenemia Prolonged

A

REPTILASE TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Dysfibrinogenemia Prolonged

A

THROMBIN TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Dysfibrinogenemia Greatly prolonged

A

REPTILASE TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Test for FXIII deficiency

A

DUKERT TEST (5M Urea Solubility Test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

DUKERT TEST (5M Urea Solubility Test)

Principle: clot formed in (?) is insoluble in (?) during a (?).

A

normal plasma

5M urea

24 hr incubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Indicator: If Factor XIII is deficient, the clot is dissolved in less than 24 hours by urea

A

DUKERT TEST (5M Urea Solubility Test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Clot + 5M Urea

NORMAL
FXIII Deficiency
Excessive fibrinolysis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Clot +NaCl

NORMAL
FXIII Deficiency
Excessive fibrinolysis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

-screening procedure for the assessment of fibrinolysis

A

EUGLOBULIN TEST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

-Euglobulin fraction:

A

Plasminogen, activators of plasminogen, fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

-EUGLOBULIN TEST

Principle: Plasma euglobulins are precipitated with (?). Precipitates are redissolved and clotted with (?). The clot is incubated and the time for complete lysis @ (?) is measured.

A

1 %Hac

thrombin

37 deg celcius

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

EUGLOBULIN TEST NV:

A

2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

: abnormal fibrinolytic activity

A

<2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

EUGLOBULIN TEST Increase fibrinolytic activity is seen on:

A

-circulatory collapse
-adrenalin injection
-sudden death
-pulmonary surgery
-pyrogen reaction
-obstetric complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

: Rapid clot breakdown

A

Primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

-increase in the circulating tPA binding to fibrin

A

Primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

-Excess tPA

A

Primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

-Excess tPA 2:

A

decreased hepatic clearance
decreased fibrinolytic inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Secondary: Secondary to

A

systemic hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

-systemic or microvascular

A

Secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

-not localized

A

Secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

-commonly assoc with DIC

A

Secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

-detects fibrin monomers

A

PROTAMINE SULFATE TEST and ETHANOL GELATION TEST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

-distinguishes primary vs secondary fibrinolysis

A

PROTAMINE SULFATE TEST and ETHANOL GELATION TEST

108
Q

-screening procedure in diagnosing DIC

A

PROTAMINE SULFATE TEST and ETHANOL GELATION TEST

109
Q

PROTAMINE SULFATE TEST and ETHANOL GELATION TEST

Principle: (?) displaces the (?) from (?) and spontaneously form (?) (paracoagulation)

A

Protamine sulfate/ 50% ethanol

secondary FDPs

fibrin monomer

gel-like clots

110
Q

PROTAMINE SULFATE TEST and ETHANOL GELATION TEST Normal:

A

no gel formation

111
Q

arises from the degradation of cross linked fibrin

A

D-d

112
Q

-measures fibrinolysis but not fibrinogenolysis

A

D-Dimer Test

113
Q

-uses latex bead with monoclonal ab

A

D-Dimer Test

114
Q

-NV: <200 ng/mL

A

D-Dimer Test

115
Q

D-Dimer Test Increased in:

A

DIC
Thrombosis
Phlebitis

116
Q

Test for FSP

A

THROMBO-WELCOTEST

117
Q

-THROMBO-WELCOTEST

Whole blood is added to (?’ to ensure complete clotting and (?) after incubation, the px serum is diluted and mixed with (?) that have been coated with (?).

A

thrombin

soya bean enzyme inhibitor

latex particles

anti-fibrin split products

118
Q

caused by traumatic phlebotomy

A

TISSUE THROMBOPLASTIN CONTAMINATION

119
Q

: contains tissue factor (TF) released from injured cells that causes premature activation of extrinsic pathway (starts coagulation prior to testing)

A

tissue thromboplastin

120
Q

e.g., release of [?] during probing, through and through puncture to the vein

A

TF

121
Q

: probing is detrimental to the results

A

sodium citrate in coagulation tests (PT, APTT)

122
Q

: probing can be considered

A

EDTA

123
Q

TISSUE THROMBOPLASTIN CONTAMINATION
effect:

A

falsely shortened test result

124
Q

Effect: use of plastic centrifuge tubes

A

alsely shortened coagulation time

125
Q

room V and VIII easily deteriorates

A

Room Temperature (18-24 C)

126
Q

stable for 24 hrs:

A

• PT plasma (remained capped until use)

127
Q

stable for 4 hrs:

A

• APTT samples
• factor assay samples

128
Q

VII and XI deteriorates

A

Ref/Cold Temperature

129
Q

prevention: by pulling the plunger in sync with the speed of blood flow to the tube

A

frothing of sample

130
Q

improper transfer from barrel to tube (frothing on top layer of blood)
• remedy: [?] (remove cap and let the blood run to the walls of tube)

A

recap

131
Q

• transfer of blood from syringe to the rubber ([?]): only done in microbiology (bacteria is still present in hemolyzed samples)

A

SPS in yellow tube or goldtop

132
Q

blue top:
EDTA:

A

4-5x

8x

133
Q

Short draw (< 2.7 mL)

A

PT/PTT falsely prolonged

134
Q

Failure to mix specimen after collection

A

PT/PTT falsely prolonged

135
Q

Excess vigorous mixing

A

PT/PTT falsely shortened

136
Q

Hemolysis

A

PT/PTT falsely shortened

137
Q

Improper storage: wrong temperature or held too long

A

PT/PTT falsely prolonged

138
Q

Chilling in refrigerator or placing on ice

A

PT/PTT falsely shortened

139
Q

Inadequate centrifugation

A

PTT loses sensitivity for lupus anticoagulants and heparin.

140
Q

Prolonged tourniquet application

A

Falsely elevates vWF, factor VIII

141
Q

Drawing coagulation tube after to other anticoagulant tubes

A

PT/PTT falsely affected

142
Q

Probing the vein

A

PT/PTT falsely shortened

143
Q

Heparin contamination from line draw

A

PT/PTT falsely prolonged

144
Q

Lipemia

A

Test may not work

145
Q

Winged-needle sets needle gauge:

A

G23

146
Q

for difficult or fragile veins; commonly used on babies, young children, and the elderly to draw blood or to administer medication using an IV

A

Winged-needle sets

147
Q

▪ disadvantage: insoluble complex or precipitate of calcium oxalate interfere with spectrophotometric reading (optical density) incorporated in the automations of hematology coagulation machines

A

SODIUM OXALATE

148
Q

combine with calcium in the blood to form insoluble complex or precipitate of calcium oxalate which causes depletion of calcium necessary for coagulation of blood

A

SODIUM OXALATE

149
Q

such as in the use of PPP that is often recalcified (addition of calcium)

A

SODIUM OXALATE

150
Q

less commonly used in hematology

A

SODIUM OXALATE

151
Q

self-filling tube (due to vacuum)

A

TRISODIUM CITRATE

152
Q

: presence of excess unbound citrate (prolongs the test)

A

incomplete filling

153
Q

: may cause underfilling

A

high hematocrit (viscous blood)

154
Q

(blood: anticoagulant)

A

9:1 ratio

155
Q

coagulation reagents are sensitive to

A

citrate

156
Q

concentrations:

A
  1. 3.2% (light blue)
  2. 3.8% (black)
157
Q

3.2% (light blue)

  • formulation:
A

0.105 M (glass) or 0.109 M (plastic)

158
Q
  • preferred for coagulation tests (PT and APTT)
A

3.2% (light blue)

159
Q

3.8% (black) formulation:

A

0.129 M

160
Q

overanticoagulation with high hematocrit blood samples (extra unbound citrate)

A

3.8% (black)

161
Q

not used on coagulation studies (thrombin is inhibited)

A

HEPARIN

162
Q

action: chelation of calcium

A

EDTA

163
Q

FV is unstable in its presence (may cause deterioration)

A

EDTA

164
Q

: plain discard tube to contain initial blood volume that may be contaminated with tissue thromboplastin)

A

a. Red stopper

165
Q

: all other following tubes affect coagulation tests

A

b. Blue stopper (3.2%)

166
Q

: chelates calcium thus must follow after tubes for coagualation tests (citrates)

A

c. Lavender stopper

167
Q

: for additional tests (emergency purposes)

A

d. Plastic Syringe

168
Q

any changes in the pH can

A

prolong clotting/coagulation time

169
Q

uncapping and capping of the tube mediates the loss of carbon dioxide making the sample suffer from

A

alkalosis

170
Q

rough test for intrinsic and common pathway (not reliable)

A

LEE AND WHITE METHOD

171
Q

addition of an activator (diatome) in the blood must cause enhanced clotting time

A

ACTIVATED CLOTTING TIME

172
Q

with the same value in Lee and White method (7-15 mins) indicates problem in coagulation

A

ACTIVATED CLOTTING TIME

173
Q

normal PPP and PRP contains all necessary components to generate fibrin clot except

A

calcium

174
Q

: x calcium; ✓ PPL

A
  • PRP
175
Q

: x calcium; x PPL

A
  • PPP
176
Q

PLASMA RECALCIFICATION TIME

recalcification (?) must coagulate and form fibrin clot

A

addition of calcium to PRP and PPP

177
Q

one of the most important tests

A

ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT/PTT)

178
Q

to determine/differentiate whether the patient has factor deficiency or just under heparin therapy

A

APTT

179
Q
  • used as a treatment for clotting to ensure normal blood flow
A

heparin therapy

180
Q
  • inhibits thrombin by acting on antithrombin-III
A

heparin therapy

181
Q

targets of heparin:

A
  • FII - FX
182
Q

may be caused by heparin therapy and not by factor deficiency

A

• prolonged APTT/PT

183
Q

• fraction of plasma which contains TF and PPL

A

thromboplastin

184
Q

thromboplastin
• two types:

A

complete: provides both TF and PPL
incomplete: only provides PPL

185
Q

: provides both TF and PPL

A

complete thromboplastin

186
Q

: only provides PPL

A

incomplete thromboplastin

187
Q

• in APTT: incomplete thromboplastin is used thus called

A

partial thromboplastin time

188
Q

refrigerated thus, shift it in a body temperature

A

APTT

189
Q

reagent does not need incubation, just invert it to maintain the suspension and prevent concentration of reagent at the bottom.

A

APTT

190
Q

APTT Deficiency in intrinsic/common pathway factors:

A

XI, IX, VIII, V, X, II, I

191
Q

circulating inhibitor: autoantibodies such as lupus anticoagulant

A

APTT

192
Q

: a powerful inhibitor of thrombin in APTT

A

E dimer/Fragment E

193
Q

: inhibit thrombin (no cleaving of fibrinogen into fibrin) in APTT

A

presence of FSP

194
Q

use of PRP: presence of numerous platelets will try to react potentially thus falsely prolonging the test

A

APTT

195
Q

TEST FOR EXTRINSIC AND COMMON PATHWAY
involves factors:
except

A

VII, TF, X, V, II, I

FXIII

196
Q

: vitamin K antagonists

A

coumadin and warfarin

197
Q

coumadin and warfarin consequently affects Vitamin K-dependent factors:

A

FII, FVII, FIX, FX (prothrombin group)

198
Q

DO NOT INCUBATE SAMPLES AT 37 C FOR LONGER THAN 5 MINUTES TO AVOID THE LOSS OF FV and FVIII.

A

Tilt Tube Technique

199
Q

Expected PT (Manual): presence of coagulum in 12-15 seconds (if not within the range, defective reagent)

A

Tilt Tube Technique

200
Q

Note: A control plasma should be run together with the test to validate the reagents used

A

Tilt Tube Technique

201
Q

the closer to 1, the more sensitive the reagent

A

International Sensitivity Index (ISI)

202
Q

optimal ISI:

A

1.3-1.5

203
Q

the PT reagent is calibrated against WHO thromboplastin reagent

A

International Sensitivity Index (ISI)

204
Q

: first to disappear (very labile in vivo) with intake of oral anticoagulant and during liver disease

A

Factor VII

205
Q

• affects both PT (falsely prolonged) and APTT (more prominent; prolonged) in PT

A

heparin contamination

206
Q

Shortened due to traumatic venipuncture (probing): contamination of tissue factor

A

PT

207
Q

assay similar to the prothrombin time

A

STYPVEN TIME/RUSSELL’S VIPER VENOM TEST

208
Q

“Vipera ruselli/ Daboia ruselli” with a thromboplastin-like action (has [?])

A

TF and FVIII

209
Q

contains a potent activator of FX which in the presence of PPL, prothrombin, and calcium ions cleaves fibrinogen to fibrin

A

“Vipera ruselli/ Daboia ruselli”

210
Q

triggers coagulation at the level of factor X

A

STYPVEN TIME/RUSSELL’S VIPER VENOM TEST

211
Q

: prolonged Russell viper venom clotting time (> 10 secs)

A

FX deficiency

212
Q
  • no clotting occurs even with the addition of venom (containing TF and FVII) to PPP
A

FX deficiency

213
Q
  • prolonged PT and PTT
A

FX deficiency

214
Q

: does not prolong (normal) the Russell viper venom clotting time and results to formation of clot

A

FVII deficiency

215
Q

• inhibits most coagulation factors

A

lupus anticoagulant

216
Q

lupus anticoagulant
• usually targets

A

FV, FVIII and FX

217
Q

• its presence causes massive bleeding

A

lupus anticoagulant

218
Q

• involved in DIC

A

lupus anticoagulant

219
Q

addition of thrombin does not require the activation of other coagulation factors in the cascade to cleave fibrinogen

A

THOMBIN TIME

220
Q

THOMBIN TIME

sample:
reagents:

A

sample: citrated PPP
reagents: standardized thrombin solution and calcium

221
Q

estimates fibrinogen concentration (thrombin time is proportional to the rate of fibrinogen polymerization

A

THOMBIN TIME

222
Q

also used to monitor heparin therapy (more accurate than APTT)

A

THOMBIN TIME

223
Q

sensitive to presence of increased levels of FSP

A

THOMBIN TIME

224
Q

: considers heparin, intrinsic and common pathway factors

A
  • APTT
225
Q

: determine thrombin concentration and heparin

A
  • thrombin time
226
Q
  • lacks protein fibrinogen or liver only starts to produce it
A

newborns

227
Q
  • has abnormal proteins (paraproteins) that impairs fibrinogen
A

multiple myeloma

228
Q

used to confirm presence of fibrinogen deficiency in patients undergoing heparin therapy as it only affects thrombin ( [?]is a thrombin-like substance only thus not affected)

A

reptilase

229
Q

absence of fibrin polymerization with the addition of reptilase indicates

A

fibrinogen deficiency

230
Q

confirm presence of FSP through test for fibrinolysis

A

REPTILASE TIME

231
Q

FXIII stabilizes fibrin clot so plasmin cannot dissolve it easily

A

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII

232
Q

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII
: same mechanism with plasmin

A

urea

233
Q

no dissolution of clot with NaCl salts

A

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII

234
Q

high concentrations of salt could precipitate protein

A

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII

235
Q

denatured proteins (thru heat or high CHON concentration) will initiate structure modification to become more stable (not easily destroyed)

A

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII

236
Q

salts modified the protein structure (especially fibrinogen which has highest concentration) and makes clot solid as it is precipitated already (insoluble clot)

A

DUKERT TEST (5 M UREA SOLUBILITY TEST) — TEST FOR FACTOR XIII

237
Q

plasmin keeps on working in fibrinogen to produce FDP or fibrin degradation products

A

PRIMARY FIBRINOLYSIS

238
Q

not cleared by macrophages thus continued activation of plasminogen (increases plasmin)

A

PRIMARY FIBRINOLYSIS

239
Q

plasmin simultaneously acts with clotting (normal)

A

SECONDARY FIBRINOLYSIS

240
Q

coagulation in the brain but fibrinolysis is activated on other body parts (not useful)

A

SECONDARY FIBRINOLYSIS

241
Q

keeps on activating plasmin but not used as coagulation occurred in other area

A

SECONDARY FIBRINOLYSIS

242
Q

D-dimer is seen: indicates in vivo fibrinolysis

A

SECONDARY FIBRINOLYSIS

243
Q

obstetric complications (pregnancy)

A

SECONDARY FIBRINOLYSIS

244
Q

increased plasminogen or plasmin

A

Abnormal fibrinolytic activity: (<2 hours)

245
Q

opposite to coagulation tests

A

Abnormal fibrinolytic activity: (<2 hours)

246
Q

abnormal results cause prolong coagulation; abnormal test when lysis of fibrin is shortened

A

EUGLOBULIN TEST

247
Q

displaces the secondary FDPs from fibrin monomer and spontaneously form gel-like clots (paracoagulation)

A

Protamine sulfate / 50% ethanol

248
Q

when there is paracoagulation, this means that the d-dimer is still crosslinks with other fibrin monomers

A

PROTAMINE SULFATE TEST AND ETHANOL GELATION TEST

249
Q

PROTAMINE SULFATE TEST AND ETHANOL GELATION TEST

gel-like clots:

A

presence of FDPs

250
Q

confirmation after performing reptilase time

A

PROTAMINE SULFATE TEST AND ETHANOL GELATION TEST

251
Q

specific marker for fibrin formation

A

D-DIMER TEST

252
Q

the detection of D dimer is not good

A

D-DIMER TEST

253
Q

• plasmin should stop at FDPs and be removed from the circulation

A

D-DIMER TEST

254
Q

• it is not safe that clots are dissolved into FDP due to anticoagulant properties

A

D-DIMER TEST

255
Q

presence of D dimer:
absence of D dimer:

A

flocculation
no flocculation

256
Q

D-DIMER TEST
normal values:

A

<200 ng/mL

257
Q

anti-FPS will be added to the blood

A

THROMBO-WELLCOTEST

258
Q

• presence of FPS:
• absence of FPS:

A

THROMBO-WELLCOTEST

flocculation (small aggregates)

no flocculation

259
Q

confirmatory test after protamine sulfate test wherein there is abnormal result and when the D-dimer test is negative

A

THROMBO-WELLCOTEST

260
Q

tests for abnormal fibrinolytic activity

A

EUGLOBULIN TEST

261
Q

determines what causes abnormal fibrinolytic activity or distinguishes primary vs secondary fibrinolysis

A

PROTAMINE SULFATE TEST AND ETHANOL GELATION TEST

262
Q

PROTAMINE SULFATE TEST AND ETHANOL GELATION TEST
No gel formation Primary fibrinolysis (?)
Gel formation (positive) Secondary fibrinolysis (?)

A

excess tPA; administer inhibitors needed

presence of FDPs

263
Q

to confirm if D-dimer is the cause of the abnormality (if negative)

A

D-DIMER TEST

264
Q

to confirm other FSP products (X, Y) which may cause the abnormality

A

THROMBO-WELLCOTEST

265
Q

(determine specific factor deficiency)

A

• factor assay samples

266
Q

its presence is specific of fibrin formation

A

D-d